| 英文名称 | 中文名称 | CAS |
|---|---|---|
| MK-1775 | MK-1775 | 955365-80-7 |
| Ponatinib-HCl; AP24534-HCl | 普纳替尼盐酸盐；普纳替尼单盐酸盐 | 1114544-31-8 |
| CC-223 | CC-223 | 1228013-30-6 |
| ABT-639 | ABT-639 | 1235560-28-7 |
| GSK591; EPZ-015866 | GSK591 (EPZ-015866) | 1616391-87-7 |
| MS023; MS-023 | N1-甲基-N1-[[4-[4-(异丙氧基)苯基]-1H-吡咯-3-基]甲基]-1,2-乙二胺 | 1831110-54-3 |
| CHIR-090 | CHIR 090 | 728865-23-4 |
| SH-4-54 | SH-4-54 | 1456632-40-8 |
| EW-7197 | EW-7197 | 1352608-82-2 |
| LY294002;LY-294002 | LY294002/PI3K抑制剂 | 154447-36-6 |
| Lasmiditan | 拉米地坦 | 439239-90-4 |
| MK-4101 | 5-(3,3-二氟环丁基)-3-[4-[4-甲基-5-[2-(三氟甲基)苯基]-4H-1,2,4-三唑-3-基]双环[2.2.2]辛烷-1-基]-1,2,4-恶二唑 | 935273-79-3 |
| GDC-0084; GDC 0084 | GDC-0084 | 1382979-44-3 |
| AG-221; Enasidenib | 恩西地平 | 1446502-11-9 |
| BDA-366 | 1-[[(2S)-3-(二乙基氨基)-2-羟基丙基]氨基]-4-[[(2S)-2-环氧乙烷基甲基]氨基]-9,10-蒽醌 | 1909226-00-1 |
| GNE-3511 | 化合物GNE-3511 | 1496581-76-0 |
| BP-1-102 | 4-(N-(4-环己基苄基)-2-((2,3,4,5,6-五氟-N-甲苯基)磺酰氨基)乙酰氨基)-2-羟基苯甲酸 | 1334493-07-0 |
| XMD8-87 | 5,11-二氢-2-((2-甲氧基-4-(4-甲基-1-哌嗪基)苯基)氨基)-11-甲基-6H-嘧啶并[4,5-B][1,4]苯并二氮杂卓-6-酮 | 1234480-46-6 |
| XMD16-5 | 2-((4-(4-羟基哌啶-1-基)苯基)氨基)-11-甲基-5H-苯并[E]嘧啶并[5,4-B][1,4]二氮杂卓-6(11H)-酮 | 1345098-78-3 |
| RAF-709 | 化合物RAF709 | 1628838-42-5 |
| Mivebresib; ABBV-075 | 米维布塞 | 1445993-26-9 |
| BAY-876 | BAY-876 | 1799753-84-6 |
| SUN11602; SUN-11602 | 化合物SUN 11602 | 704869-38-5 |
| Acebilustat | 阿西鲁司特 | 943764-99-6 |
| CP-21R7 | GSK-3Β抑制剂(CP21R7) | 125314-13-8 |
| GSK-189254A | 6-(3-CYCLOBUTYL-2,3,4,5-TETRAHYDRO-1H-BENZO[D]AZEPIN-7-YLOXY)-N-METHYLNICOTINAMIDE | 720690-73-3 |
| UK-371804; Urokinase inhitibor 1 | 化合物UK371804 | 256477-09-5 |
| E 7449; E-7449 | E7449 | 1140964-99-3 |
| NCB-0846 | NCB-0846 | 1792999-26-8 |
| ETP-46321 | CS-2500 | 1252594-99-2 |
| Q203 | Q203 | 1334719-95-7 |
| STK16-IN-1 | 化合物STK16-IN-1 | 1223001-53-3 |
| MK-4827 tosylate; Niraparib tosylate | MK-4827 tosylate; Niraparib tosylate; Niraparib对甲苯磺酸盐; MK-4827 对甲苯磺酸盐 | 1038915-73-9 |
| AMG-3969 | AMG-3969 | 1361224-53-4 |
| GSK-2256098 | GSK-2256098 | 1224887-10-8 |
| GSK2982772 | GSK2982772 | 1622848-92-3 |
| CPI-637 | (R)-4-甲基-6-(1-甲基-3-(1-甲基-1H-吡唑-4-基)-1H-吲唑-5-基)-4,5-二氢-1H-苯并[B][1,4]二氮杂-2(3H)-酮 | 1884712-47-3 |
| T0901317 | N-(2,2,2-三氟乙基)-N-[4-[2,2,2-三氟-1-羟基-1-(三氟甲基)乙基]苯基]苯磺酰胺 | 293754-55-9 |
| NCGC00244536 | 3-(8-羟基喹啉-6-基)-N-(3-苯基丙基)苯甲酰胺 | 2003260-55-5 |
| GBT-440 | 沃塞洛托 | 1446321-46-5 |
| SRT-2104 | 玻玛西林 | 1093403-33-8 |
| Pexidartinib | N/A | 1029044-16-3 |
| Grapiprant | GRAPIPRANT | 415903-37-6 |
| NVS-PAK1-1 | NVS-PAK1-1 | 1783816-74-9 |
| Icotinib hydrochloride | Icotinib hydrochloride; 埃克替尼盐酸盐 | 1204313-51-8 |
| Lasmiditan hydrochloride | 613677-28-4 | 613677-28-4 |
| Lasmiditan hemisuccinate | 琥珀酸拉斯米迪坦 | 439239-92-6 |
| OICR-9429 | OICR-9429 | 1801787-56-3 |
| SH5-07; SH-5-07 | 1456632-41-9 | 1456632-41-9 |
| 1-methyl-3-amino-4-cyanopyrazole | 1-甲基-3-胺基-4-氰基吡唑 | 21230-50-2 |
| 6-bromo-[1,2,4]triazolo[1,5-a]pyridine | 6-溴-[1,2,4]三唑并[1,5-a]吡啶 | 356560-80-0 |
| 2-(2-chloro-6-morpholino-9H-purin-8-yl)propan-2-ol | 2-(2-氯-6-吗啉代-9H-嘌呤-8-基)丙-2-醇 | 1198171-62-8 |
| GSK-3326595;EPZ-015938 | GSK-3326595 | 1616392-22-3 |
| Ticagrelor | 替卡格雷，替格雷洛，替格瑞洛 | 274693-27-5 |
| All-rac-alfa-TocopherolEP impurity C | 生育酚杂质C | 10191-41-0 |
| AZD7986 | AZD7986 | 1802148-05-5 |
| 4-bromo-2-methoxyaniline | 4-溴-2-甲氧基苯胺 | 59557-91-4 |
| 3-nitro-4-((tetrahydro-2H-pyran-4-yl)MethylaMino)benzenesulfonaMide | ABT199 中间体 | 1228779-96-1 |
| Fevipiprant | 非韦匹仑 | 872365-14-5 |
| CP-609754 (OSI754) | CP-609754 | 1190094-64-4 |
| (6-aminopyridin-2-yl)(1-methylpiperidin-4-yl)methanone hydrogen bromide | LASMIDITAN 中间体 | 1338000-32-0 |
| EPZ-015666;GSK3235025;GSK-3235025;EPZ-015666 | EPZ015666 | 1616391-65-1 |
| Vipadenant; BIIB 014 | 3-(4-氨基-3-甲基苄基)-7-(呋喃-2-基)-3H-[1,2,3]三唑并[4,5-D]嘧啶-5-胺 | 442908-10-3 |
| GS-9620 | GS9620 | 1228585-88-3 |
| Defactinib: VS-6063: PF-04554878 | 地法替尼 | 1073154-85-4 |
| Defactinib hydrochloride; VS-6063; PF-04554878 | PF-04554878 | 1073160-26-5 |
| TAK-632; TAK-0632 | TAK-632 | 1228591-30-7 |
| UNC1215 | UNC1215 | 1415800-43-9 |
| BX-471; ZK-811752 | (R)-1-(5-氯-2-(2-(4-(4-氟苄基)-2-甲基哌嗪-1-基)-2-氧代乙氧基)苯基)脲 | 217645-70-0 |
| PFI-3 | (2E)-1-(2-羟基苯基)-3-[(1R,4R)-5-(2-吡啶基)-2,5-二氮杂双环[2.2.1]庚-2-基]-2-丙烯-1-酮 | 1819363-80-8 |
| ML324 | ML324 | 1222800-79-4 |
| AC 55541 | AC-55541 | 916170-19-9 |
| HTH-01-015 | HTH-01-015 | 1613724-42-7 |
| THZ1 | THZ1 | 1604810-83-4 |
| Liproxstatin-1 | 利普司他丁-1 | 950455-15-9 |
| SKF-86002 | 6-(4-氟苯基)-5-(4-吡啶基)-2,3-二氢咪唑并[2,1-B]-噻唑 | 72873-74-6 |
| AC-710 | N-[4-[[[[5-(叔丁基)-3-异恶唑基]氨基]羰基]氨基]苯基]-5-[(1-乙基-2,2,6,6-四甲基-4-哌啶基)氧基]-2-吡啶甲酰胺 | 1351522-04-7 |
| Emapunil; AC-5216 | AC-5216 | 226954-04-7 |
| SD-208 | SD-208 | 627536-09-8 |
| RGB-286638 | N-[1,4-二氢-3-[4-[[4-(2-甲氧基乙基)-1-哌嗪基]甲基]苯基]-4-氧代茚并[1,2-C]吡唑-5-基]-N'-4-吗啉基脲 | 784210-88-4 |
| Pilaralisib; XL147 | 2-氨基-N-[3-[N-[3-[(2-氯-5-甲氧基苯基)氨基]喹喔啉-2-基]氨基磺酰基]苯基]-2-甲基丙酰胺 | 934526-89-3 |
| SAR245408; XL-147 | XL147 | 956958-53-5 |
| AMG-319 | AMG319 | 1608125-21-8 |
| CEP-33779 | N-[3-(4-甲基-1-哌嗪基)苯基]-8-[4-(甲磺酰基)苯基]-[1,2,4]三唑并[1,5-A]吡啶-2-胺 | 1257704-57-6 |
| UNC2025 | 反式-4-[2-(丁基氨基)-5-[4-[(4-甲基-1-哌嗪基)甲基]苯基]-7H-吡咯并[2,3-D]嘧啶-7-基]-环己醇 | 1429881-91-3 |
| Coelenterazine | 腔肠素 | 55779-48-1 |
| Motolimod; VTX-2337 | MOTOLIMOD | 926927-61-9 |
| GSK-163090 | GSK163090 | 844903-58-8 |
| CWHM-12 | CWHM-12 | 1564286-55-0 |
| MK-8776 | SCH-900776 | 891494-64-7 |
| Galeterone | Galeterone | 851983-85-2 |
| MCC-950 Sodium | MCC950 | 210826-40-7 |
| Binimetinib; MEK-162; ARRY-162;ARRY-438162 | 贝美替尼 | 606143-89-9 |
联系方式
